---
title: "SL Science slips 8% in premarket as FY2025 loss widens to $3.8M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291774343.md"
description: "SLBT falls 8% premarket to $5.50 after reporting wider FY2025 loss and 35% revenue decline."
datetime: "2026-07-06T08:30:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291774343.md)
  - [en](https://longbridge.com/en/news/291774343.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291774343.md)
---

# SL Science slips 8% in premarket as FY2025 loss widens to $3.8M

SL Science(SLBT.US) 盘前跌**8.18%**，现报**5.5**美元。

公司 2025 财年净亏损扩大至**382**万美元，营收同比下降**35%**至**220**万美元，主要受台湾外泌体业务从零售转向批发影响。前一交易日正则涨幅达**34.61%**，短期波动显著。

### Related Stocks

- [SLBT.US](https://longbridge.com/en/quote/SLBT.US.md)

## Related News & Research

- [SL Science Seeks FDA Orphan Drug Status for Gamma Delta T Cell Therapy in Glioblastoma](https://longbridge.com/en/news/292326758.md)
- [SL Science Holding files Form 3 as CEO Ching-Dong Wang reports 333,832,129 shares beneficially owned](https://longbridge.com/en/news/290244372.md)
- [Ching-Dong Wang Discloses Investment at SL Science Holding Ltd with 59.53% Stake](https://longbridge.com/en/news/290245423.md)
- [SL Science FY25 net loss widens to USD 3.82 million; revenue falls 35% to USD 2.2 million](https://longbridge.com/en/news/290247592.md)
- [SL Science Holding Limited Reports Full Year 2025 Financial Results | SLBT Stock News](https://longbridge.com/en/news/290247925.md)